Relapsed/Refractory Multiple Myeloma

Clinical Trials

The following is a list of clinical trials for relapsed/refractory multiple myeloma that are currently recruiting myeloma patients in the United States. You can use the buttons below to sort the listings by trial phase as well as distance.

Other ways to search
Find a trial that's right for you by personalizing your search.
Browse our myeloma treatment center directory to find a myeloma specialist near you.

Sort By Distance

Need Help?

Call SparkCures and one of our clinical trial specialists will help answer your questions.

(888) 828-2206

A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus

A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-573 in Participants With Refractory Multiple Myeloma

The purpose of this Phase 1 portion of the study is to determine the safety and tolerability of TAK-573 monotherapy in participants with refractory multiple myeloma (MM) and Phase 2a portion of the study is to provide a preliminary evaluation of the clinical activity of TAK-573 monotherapy in participants with refractory MM.

Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma

This phase I/II trial studies the side effects and best dose of idasanutlin and ixazomib citrate when given together with dexamethasone in treating patients with multiple myeloma that has returned after a period of improvement.

Phase I Trial of BAY1251152 for Advanced Blood Cancers

The purpose of this study is to identify the most appropriate dose that can be safely administered and that can have an effect on blood cancer cells. Once that safe dose is identified, additional patients will be asked to join the study to further evaluate the safety and effectiveness BAY1251152.

A Phase 1 Study in Subjects With Relapsed or Refractory Multiple Myeloma

Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

MMRF Molecular Profiling Protocol

Multiple Myeloma Patient Registry

  • Accepting patients
  • Observational Trial
  • 1 location